BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17075968)

  • 21. Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat.
    Prieto I; Aller MA; Santamaría L; Nava MP; Madero R; Pérez-Robledo JP; Arias J
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1025-31. PubMed ID: 15955210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Morpho-functional changes in the vascular bed in obstructed portal blood flow].
    Dyskin EA; Gaĭvoronskiĭ IV; Eremenko VP
    Vestn Khir Im I I Grek; 1990 May; 144(5):46-50. PubMed ID: 2175983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sinusoidal microcirculatory changes after small-for-size liver transplantation in rats.
    Li J; Liang L; Ma T; Yu X; Chen W; Xu G; Liang T
    Transpl Int; 2010 Sep; 23(9):924-33. PubMed ID: 20210931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beneficial effects of curcumin in cirrhotic rats with portal hypertension.
    Hsu SJ; Lee JY; Lin TY; Hsieh YH; Huang HC; Lee FY; Lin HC; Hou MC; Lee SD
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic microcirculation and mechanisms of portal hypertension.
    Gracia-Sancho J; Marrone G; Fernández-Iglesias A
    Nat Rev Gastroenterol Hepatol; 2019 Apr; 16(4):221-234. PubMed ID: 30568278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stellate cells and the "reversible component" of portal hypertension.
    de Franchis R
    Dig Liver Dis; 2000 Mar; 32(2):104-7. PubMed ID: 10975782
    [No Abstract]   [Full Text] [Related]  

  • 27. [Portal hypertension and the endothelium].
    Marecková Z; Horký K
    Cesk Fysiol; 2001 Feb; 50(1):19-24. PubMed ID: 11268558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation: a way to understanding the evolution of portal hypertension.
    Aller MA; Arias JL; Cruz A; Arias J
    Theor Biol Med Model; 2007 Nov; 4():44. PubMed ID: 17999758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver fibrosis emulation: Impact of the vascular fibrotic alterations on hemodynamics.
    Torres Rojas AM; Lorente S
    Comput Biol Med; 2023 Nov; 166():107563. PubMed ID: 37852110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental prehepatic portal hypertension--the development and treatment of esophageal varices.
    Jensen LS
    Dan Med Bull; 1988 Oct; 35(5):401-13. PubMed ID: 3066586
    [No Abstract]   [Full Text] [Related]  

  • 32. Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
    Mejias M; Garcia-Pras E; Tiani C; Miquel R; Bosch J; Fernandez M
    Hepatology; 2009 Apr; 49(4):1245-56. PubMed ID: 19137587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis and portal-systemic collaterals in portal hypertension.
    Gana JC; Serrano CA; Ling SC
    Ann Hepatol; 2016; 15(3):303-13. PubMed ID: 27049484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathogenesis of portal hypertension].
    Montaño-Loza A; Meza-Junco J
    Rev Invest Clin; 2005; 57(4):596-607. PubMed ID: 16315644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
    Gatta A; Bolognesi M; Merkel C
    Mol Aspects Med; 2008; 29(1-2):119-29. PubMed ID: 18036654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension.
    Van Steenkiste C; Geerts A; Vanheule E; Van Vlierberghe H; De Vos F; Olievier K; Casteleyn C; Laukens D; De Vos M; Stassen JM; Carmeliet P; Colle I
    Gastroenterology; 2009 Dec; 137(6):2112-24.e1-6. PubMed ID: 19751735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
    Fernandez M; Mejias M; Garcia-Pras E; Mendez R; Garcia-Pagan JC; Bosch J
    Hepatology; 2007 Oct; 46(4):1208-17. PubMed ID: 17654489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH; Nishida O; Tokubayashi M; Kimura F; Takimoto Y; Yoshioka H; Inque R; Kita T
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous treatment of portal hypertension and hepatic cirrhosis by splenohepatoplasty.
    Vara-Thorbeck R; Maza-Inza J
    Surg Gynecol Obstet; 1978 Sep; 147(3):391-6. PubMed ID: 684592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamics in the microvasculature of thioacetamide-induced cirrhotic rat livers.
    Nakata M; Nakamura K; Koda Y; Kaminou T; Ugami M; Kaneda K; Yamada R
    Hepatogastroenterology; 2002; 49(45):652-6. PubMed ID: 12063962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.